Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients.

被引：0
|
作者：
Wang, Z. [1 ]
Han, Z. [1 ]
Tao, J. [1 ]
Chen, H. [1 ]
Sun, L. [1 ]
Tan, R. [1 ]
Gu, M. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Urol, Nanjing, Jiangsu, Peoples R China
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B125
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [31] Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
    Zuo, Xiao-cong
    Ng, Chee M.
    Barrett, Jeffrey S.
    Luo, Ai-jing
    Zhang, Bi-kui
    Deng, Chen-hui
    Xi, Lan-yan
    Cheng, Ke
    Ming, Ying-zi
    Yang, Guo-ping
    Pei, Qi
    Zhu, Li-jun
    Yuan, Hong
    Liao, Hai-qiang
    Ding, Jun-jie
    Wu, Di
    Zhou, Ya-nan
    Jing, Ning-ning
    Huang, Zhi-jun
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (05): : 251 - 261
  • [32] Mechanism-based inactivation (MBI) of recombinant CYP2C19 and CYP3A4 but not human liver microsomal CYP2C19 and CYP3A4 by nortriptyline
    Polasek, Thomas M.
    Miners, John O.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 234 - 234
  • [33] The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population
    Liou, Ya-Huei
    Lin, Chien-Ting
    Wu, Ying-Jye
    Wu, Lawrence Shih-Hsin
    JOURNAL OF HUMAN GENETICS, 2006, 51 (10) : 857 - 863
  • [34] GENETIC POLYMORPHISMS OF CYTOCHROME P450 (CYP) 2C9, CYP2C19, CYP2D6, CYP3A4, AND CYP3A5 IN A KORSIAN POPULATION
    Lim, Y.
    Kim, E.
    Lee, Y.
    Cha, E.
    Jung, H.
    Kim, J.
    Lee, S.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S61 - S61
  • [35] The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population
    Ya-Huei Liou
    Chien-Ting Lin
    Ying-Jye Wu
    Lawrence Shih-Hsin Wu
    Journal of Human Genetics, 2006, 51
  • [36] Inhibitory effects of cytochrome P450 enzymes CYP2C8, CYP2C9, CYP2C19 and CYP3A4 by Labisia pumila extracts
    Pan, Yan
    Tiong, Kai Hung
    Abd-Rashid, Badrul Amini
    Ismail, Zakiah
    Ismail, Rushli
    Mak, Joon Wah
    Ong, Chin Eng
    JOURNAL OF ETHNOPHARMACOLOGY, 2012, 143 (02) : 586 - 591
  • [37] Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam
    M. I. Veiga
    S. Asimus
    P. E. Ferreira
    J. P. Martins
    I. Cavaco
    V. Ribeiro
    T. N. Hai
    M. G. Petzold
    A. Björkman
    M. Ashton
    J. P. Gil
    European Journal of Clinical Pharmacology, 2009, 65 : 355 - 363
  • [38] Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam
    Veiga, M. I.
    Asimus, S.
    Ferreira, P. E.
    Martins, J. P.
    Cavaco, I.
    Ribeiro, V.
    Hai, T. N.
    Petzold, M. G.
    Bjorkman, A.
    Ashton, M.
    Gil, J. P.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (04) : 355 - 363
  • [39] Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population
    Krasniqi, Valon
    Dimovski, Aleksandar
    Bytyqi, Hasime Qorraj
    Eftimov, Aleksandar
    Simicevic, Livija
    Bozina, Nada
    ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY, 2017, 68 (03): : 180 - 184
  • [40] Phenazepam's safety pharmacogenetic study results: influence of CYP2C9, CYP3A5, CYP2C19, ABCB1 and CYP3A4/5 isoenzymes' activity
    Ivashchenko, D.
    Ryzhikova, K.
    Sozaeva, Z.
    Grishina, E.
    Zastrozhin, M.
    Bryun, E.
    Sychev, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 : S17 - S18
12345